Nivolumab for previously treated squamous oesophageal carcinoma

Lancet Oncol. 2019 Nov;20(11):1468-1469. doi: 10.1016/S1470-2045(19)30621-7. Epub 2019 Sep 30.

Authors

Elizabeth C Smyth¹, Florian Lordick²

Affiliations

¹ Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK. Electronic address: elizabeth.smyth@nhs.net.
² University Cancer Center, University Hospital Leipzig, Leipzig, Germany.

PMID: 31582356
DOI: 10.1016/S1470-2045(19)30621-7

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Squamous Cell*
Esophageal Neoplasms*
Esophageal Squamous Cell Carcinoma*
Humans
Nivolumab

Substances

Nivolumab